Picture of Tego Science logo

191420 Tego Science Income Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Annual income statement for Tego Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
R2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue6,3468,7898,3007,6787,772
Cost of Revenue
Gross Profit4,7156,6406,4035,6155,304
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses6,1387,2778,3987,46910,102
Operating Profit2081,512-98210-2,330
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes8642,05466.2202-2,563
Provision for Income Taxes
Net Income After Taxes8321,81047.5256-2,343
Minority Interest
Net Income Before Extraordinary Items
Net Income8561,831139265-2,323
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income8561,831139265-2,323
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS12271.317.333-197
Dividends per Share